|
Published by: Espicom Healthcare Intelligence
Published: Sep. 30, 2009 - 94 Pages
Table of Contents
- EXECUTIVE SUMMARY
- INTRODUCTION
- PHARMACEUTICAL MARKET ANALYSIS
- Size
- Market Structure
- Reimbursable Drugs - Pharmacy Sector
- Community Pharmacies
- Chronic Ailment Repeat Prescriptions Increase
- Generics Sector
- OTC Sector
- Projections & Outlook
- Imports
- Domestic Manufacturing
- Domestic Production
- Trade Associations
- Local Manufacturers
- Organon
- DSM BV
- Multipharma B.V
- Pharmachemie B.V.
- Exports
- Research & Development
- PHARMACEUTICAL REGULATORY ANALYSIS
- Pharmaceutical Regulation
- EU Drug Regulation
- Centralised Procedure
- EMEA
- Generic Drugs
- Pharmaceutical Registration
- Advertising
- Pricing & Reimbursement
- Pricing
- Medicines Covenant (2004-2007)
- Reimbursement
- Intellectual Property
- Data Exclusivity
- PHARMACEUTICAL DISTRIBUTION
- Wholesaling
- Brocacef Holding
- Interpharm Group BV (Alliance Healthcare)
- Mediq (OPG)
- Retailing
- HEALTHCARE ANALYSIS
- Demographics
- Population
- Birth Rate
- Death Rate
- Infant Mortality
- Life Expectancy at Birth
- Public Health
- Causes of Death
- Incidence of Communicable Diseases
- HIV/AIDS
- Incidence of Non-communicable Diseases
- Cancer
- Diabetes
- Healthcare System
- Dutch Healthcare Authority (NZa)
- Health Care Inspectorate (IGZ)
- Institutional Care
- Hospital Diagnosis Treatment Combinations (DBCs)
- Ambulatory Care
- Health Insurance
- Health Insurance Act
- The Exceptional Medical Expenses Act (EMEA)
- Supplementary Health Insurance
- HEALTH EXPENDITURE
- Healthcare Infrastructure
- Inpatient Analysis
- Ambulatory Activity
- Healthcare Personnel
- DIRECTORY
- Government Organisations
- Trade Associations
- Methodology & Sources
- List of Tables
- Summary of Key Data Projections, 2009-2014
- Summary of the Dutch Pharmaceutical Market, 2009
- Turnover by Sector, Manufacturers’ Prices, 2003-2008 (Million Euros)
- Market Value by Sector and Product Type, 2008
- Market Volume by Sector and Product Type, 2008
- Pharmacy Sales of Reimbursable Drugs, 2004-2008
- Pharmacy Sales of Reimbursable Drugs by Category, 2004-2008 (000s Euros)
- Pharmacy Sales of Reimbursable Drugs by Category, 2004-2008 (DDD 000s)
- Pharmacy Sales of Reimbursable Drugs by Category, 2004-2008 (Cost per DDD)
- Pharmacy Sales of Reimbursable Drugs by Category, 2004-2008 (Prescriptions 000s)
- Trends in Pharmacy Sales of Reimbursable Drugs, 2004-2008
- Top 10 Drugs by Expenditure, 2008 (Million Euros)
- Top 10 Prescribed Drugs by Prescription, 2008
- Market Share of New Drugs in Reimbursable Market, 2000-2007
- Market Share of New Drugs in Reimbursable Market, 2000-2007
- Community Pharmacy Drug Sales, 2003-2007
- Generic Share of Pharmacy Market by Volume, 2003-2007 (Million Prescriptions)
- Generic Share of Pharmacy Market by Value, 2003-2007 (Million Euros)
- Generic Share of Hospital Market, 2007-2008
- Top 10 Generic Drugs by Prescription, 2007
- OTC Market by Therapeutic Area, 2004-2008 (Million Euros)
- OTC Market by Point of Sale, 2008
- OTC Market by Therapeutic Area & Point of Sale, 2008 (Million Euros)
- Market Projections, 2009-2014
- Espicom Analysis of the Dutch Pharmaceutical Market, 2009
- SWOT Analysis of the Dutch Pharmaceutical Market, 2009
- Pharmaceutical Imports by Category, 2004-2008 (US$ Millions)
- Pharmaceutical Import Trends
- Leading Suppliers of Pharmaceuticals, 2008 (US$000s)
- Leading Suppliers of Raw Materials, 2008 (US$000s)
- Leading Suppliers of Antisera & Vaccines, 2008 (US$000s)
- Leading Suppliers of Medicaments, 2008 (US$000s)
- Pharmaceutical Industry Indicators, 1995-2006
- Pharmaceuticals Exports by Category, 2004-2008 (US$ millions)
- Pharmaceutical Export Trends
- Leading Destinations of Pharmaceuticals, 2008 (US$000s)
- Leading Destinations of Raw Materials, 2008 (US$000s)
- Leading Destinations of Antisera & Vaccines, 2008 (US$000s)
- Leading Destinations of Medicaments, 2008 (US$000s)
- Research & Development Expenditure of Domestic Companies, 1995-2003 (Million Euros)
- Number of Authorised Medicinal Products, 2004-2008
- Medicinal Products Recorded in the Register, 2004-2008
- Community Pharmacies, 2003-2007
- Summary of Demographic Data
- Projected Population, 2009-2014
- Causes of Death, 2007
- Healthcare Expenditure
- Projected Health Expenditure, 2008-2013
- Hospitals & Beds
- Hospital Bed Projections, 2009-2014
- Hospital Activity, 2000-2007
- Hospital Admissions by Main Diagnosis, 2002-2007
- Hospital Admissions by Type & Main Diagnosis, 2007
- Patient Days & Average Stay by Main Diagnosis, 2007
- Ambulatory Consultations, 2003-2008
- Medical Personnel, 2003-2007
- Projected Number of Physicians, 2009-2014
- List of Charts
- Dutch Pharmaceutical Market by Sector, 2008 (%)
- Drug Consumption by Age Group & Gender, 2007 (prescriptions per person)
- Drug Expenditure by Age Group, & Gender 2007 (Euros)
- Impact of Cost Containment Measures on Pharmaceutical Spending, 2000-2012 (Million Euros)
- Radar Graph of the Dutch Pharma Market, 2009
- Pharmaceutical Imports, 2000-2008
- Change in Pharmaceutical Imports, 2001-2008 (%)
- Pharmaceutical Exports, 2000-2008
- Change in Pharmaceutical Exports, 2001-2008 (%)
AbstractEspicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts.
Please Note: this is delivered as a Zip file.
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
